Skip to main content

65 millions de dollars US levés en série B pour faire de Heidi le partenaire des professionnels de santé. Lire l’article en anglais

Heidi AI
Se connecterTestez gratuitement
Psychiatrist Template

SSP - ADHD Review Template

A professional Psychiatrist template for healthcare professionals.
Use this templateBrowse more templates
Browse more templates

About this template

Streamline your ADHD patient reviews with our comprehensive "SSP - ADHD Review Template" for psychiatrists. This essential clinical note template is expertly designed to capture all critical information during follow-up consultations. Psychiatrists will find it invaluable for documenting current medication regimens, assessing treatment response, detailing ongoing symptoms, and meticulously recording any side effects. It includes dedicated sections for physical monitoring, evaluating the medication's duration of action, documenting investigations, and performing a thorough risk assessment. Heidi's AI medical scribe intelligently populates this template, ensuring every aspect of the patient's mental state examination and a clear, actionable treatment plan is accurately recorded, allowing clinicians to focus more on patient care and less on administrative tasks. Optimise your clinical documentation with this indispensable tool.

Preview template

Specialty: Psychiatrist Current Medication: - Methylphenidate ER 36mg, once daily in the morning, oral. Patient reports good adherence, no missed doses. No recent changes. - Multivitamin, once daily, oral. Patient reports good adherence. Response to Medication: Patient reports significant improvement in ability to focus on tasks at work and during conversations since starting methylphenidate. Academic performance has improved, with fewer assignments missed and better grades. Social interactions feel less overwhelming, and patient reports being able to maintain conversations more effectively. However, patient notes that the medication's effectiveness seems to wane in the late afternoon, leading to increased distractibility during evening activities. Current Symptoms: Patient continues to experience occasional difficulties with task initiation and organisation, particularly for non-preferred activities. While inattention has largely improved with medication, some mild difficulties with sustained attention remain when fatigued. Hyperactivity is well-controlled, with less fidgeting and restlessness. Impulsivity is also reduced, though patient sometimes still interrupts others in conversation when excited. Side Effects: Patient reports mild appetite suppression, primarily in the morning, which has improved over time. Initially experienced some insomnia, but this resolved with a slight adjustment to the medication timing (taking it earlier in the morning). No other significant side effects reported. Physical Monitoring: - Weight: 72 kg (stable) - Blood pressure: 120/75 mmHg - Heart rate: 78 bpm - Sleep patterns: Generally 7-8 hours per night, occasional difficulty falling asleep if medication is taken too late. - Appetite: Mildly suppressed in the morning, otherwise normal. Duration of Action: Patient consistently reports that the effects of methylphenidate begin to wear off around 4-5 PM, approximately 8-9 hours after administration. At this point, they notice a gradual return of inattention and increased difficulty concentrating, impacting their ability to complete evening chores or engage in hobbies effectively. This decline in efficacy leads to increased frustration and a feeling of being overwhelmed in the evenings. Investigations: - Conners 3 Rating Scale (self-report and parent report) completed 3 months prior, demonstrating significant reduction in symptom scores post-medication initiation. - ECG performed 6 months ago, within normal limits. Risk Assessment: No current suicidal ideation, self-harm, or substance use. Patient has a history of mild anxiety, well-managed with non-pharmacological strategies. Protective factors include a supportive family environment and stable employment. Impulsivity-related risks are low. Plan for risk mitigation includes regular follow-up and monitoring of mood and anxiety symptoms. Mental State Examination: Patient was well-groomed and cooperative throughout the interview. Speech was of normal rate and rhythm. Mood was euthymic, and affect was congruent. Thought form was linear and logical, with no evidence of thought disorder. No perceptual disturbances reported. Cognitive function appeared intact. Insight into condition and treatment was good, and judgement was sound. Treatment Plan: - Increase Methylphenidate ER to 54mg once daily in the morning to address the reported wearing-off effect in the late afternoon. This aims to provide extended symptom control. - Advise patient to monitor for any new side effects with the dosage increase, particularly appetite and sleep disturbances. - Explore non-pharmacological strategies for evening routine management, such as setting timers or breaking down tasks into smaller steps. - Referral to occupational therapy to further develop organisational skills and executive functioning strategies. - Follow-up appointment scheduled in 4 weeks to review medication efficacy and side effects.
Current Medication: [Patient's current medication regimen including the name of each medication, dosage, frequency, and route of administration, any other medications, supplements or over-the-counter remedies currently taken, details of adherence, any recent changes in dosage or medication type, and the rationale for those changes] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write as a list with each medication on a new line.) Response to Medication: [Assessment of the patient's response to their current ADHD medication, including the perceived efficacy in managing ADHD symptoms, reported improvements in academic, occupational, or social functioning, and any areas where the medication's effectiveness appears limited] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write in paragraphs of full sentences.) Current Symptoms: [Patient's current ADHD symptoms and how they manifest in daily life, including symptoms relating to inattention, hyperactivity, and impulsivity, along with the severity, frequency, and impact of symptoms across different life domains] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write in paragraphs of full sentences.) Side Effects: [Any side effects associated with the current ADHD medication, including the nature of each side effect, its onset, duration, severity, and any actions taken to address it] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write in paragraphs of full sentences.) Physical Monitoring: [Physical parameters assessed in the context of ADHD medication monitoring, including current weight, blood pressure, heart rate, sleep patterns, and appetite, as well as any other relevant physical observations or patient-reported physical symptoms] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write as a list.) Duration of Action: [Perceived duration of action of the ADHD medication, including the approximate time at which the medication's effects are reported to wear off, patient observations regarding the return of symptoms or decline in efficacy at certain points in the day, and any impact on daily functioning] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write in paragraphs of full sentences.) Investigations: [Details of any investigations conducted or discussed, including any psychological assessments, rating scales, blood tests, or diagnostic procedures undertaken or considered, along with their findings and relevance to the patient's ADHD management] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write as a list.) Risk Assessment: [Comprehensive assessment of risks including any current or historical psychiatric comorbidities, substance use, suicidal ideation or attempts, self-harm, impulsivity-related risks, and any other psychosocial stressors that may impact the patient's wellbeing or ADHD management, along with any protective factors identified and the plan for risk mitigation] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write in paragraphs of full sentences.) Mental State Examination: [Findings of the mental state examination including observations regarding the patient's appearance, behaviour, speech, mood, affect, thought form and content, perception, cognitive function, insight, and judgement] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write in paragraphs of full sentences.) Treatment Plan: [Comprehensive treatment plan including any adjustments to medication, non-pharmacological interventions, educational strategies, referrals to other specialists, goals for treatment, follow-up arrangements, and any specific advice or recommendations provided to the patient] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note, else omit section entirely. Write in paragraphs of full sentences.)
Browse more templatesUse this template

How to use this template

Step 1: Download the template
1Step 1

Download the template

Get started by downloading the template to your device

Step 2: Customize to your needs
2Step 2

Customize to your needs

Tailor the template to match your specific requirements

Step 3: Deploy and share
3Step 3

Deploy and share

Implement your customized template and share with your team

Browse more templatesUse this template

Related Templates

Note

Psiquiatría - Nota de Evolución

Alexandra Blumer Romagni

Psychiatrist, Spain

Note

DVA Assessment

Sagir Parkar

Psychiatrist, Australia

Document

Psychiatric Assessment Report

Nosheen Sheikh

Psychiatrist, New Zealand

Start practicing with a partner

Care is better with Heidi
Use this template

Specialty

Psychiatrist

Used

121 times

Type

Note

Last edited

12/05/2026

Created by

Ben Chetcuti

Interrogez les IA à propos de Heidi :

Heidi AI

Chaque jour à vos côtés.

© 2026 Heidi. Tous droits réservés.

Spécialités

  • Médecine générale

  • Médecine spécialisée

  • Paramédical

  • Psychologie et psychiatrie

Conformité

  • Sécurité

  • Centre de confiance

Produit

  • Tarifs

  • Centre d’aide

  • État du système

À propos

  • Nous contacter

  • Témoignages client

  • Rejoindre Heidi

    10+

Ressources

  • Centre de ressources

  • Modèles créés par la communauté

Informations légales

  • Politique de confidentialité

  • Conditions d’utilisation

  • Politique d’utilisation

  • Accessibilité

  • Mentions légales